Sectorale dividenden PHAXIAM Therapeutics S.A. Euronext Paris
Aandelen
PHXM
FR0011471135
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,650 EUR | -1,55% | -0,84% | -61,19% |
12/06 | Phaxiam: kapitaalverhoging van tien miljoen euro | CF |
15/04 | Phaxiam start studie in infectieuze endocarditis | CF |
Toevoegen aan een lijst 0 geselecteerde | Dividendrendement (Y) | Dividendrendement (Y+1) | K/w-verhouding | Koers-boekwaarde | EV/omzet | Beurskap. / EBITDA | Beurskap. / EBIT | Kapi. ($) | |
---|---|---|---|---|---|---|---|---|---|
-.--% | -.--% | 31.25x | 4,300 | 8.23x | 20.05x | 22.01x | 126 mld. | ||
-.--% | -.--% | -241.53x | 7,526 | 10.57x | 139.15x | 188.43x | 124 mld. | ||
-.--% | -.--% | -527.56x | 7,377 | 14.51x | -176.25x | -167.1x | 32,07 mld. | ||
-.--% | -.--% | -43.03x | 1,161 | 3.68x | -10.61x | -8.91x | 24,97 mld. | ||
-.--% | -.--% | -32.23x | 6,260 | 5.29x | -32.51x | -26.93x | 20,85 mld. | ||
-.--% | -.--% | 21.56x | 3,404 | 4.25x | 13.92x | 14.61x | 16,71 mld. | ||
+2.43% | +2.64% | 12.11x | 1,880 | 2.64x | 7.49x | 9x | 15,91 mld. | ||
-.--% | -.--% | -25.47x | - | - | - | - | 14,12 mld. | ||
-.--% | -.--% | -14.22x | -57,705200 | 37.12x | -17.32x | -16.75x | 12,7 mld. | ||
-.--% | -.--% | 28.35x | 4,333 | 4.42x | 16.38x | 16.65x | 12,25 mld. | ||
-.--% | -.--% | 67.75x | 9,536 | 6.38x | 78.62x | 107.96x | 11,95 mld. | ||
-.--% | -.--% | -79.8x | 6,568 | 117.85x | -84.69x | -68.14x | 9,45 mld. | ||
-.--% | -.--% | -43.05x | 9,763 | 15.14x | -29.83x | -26.22x | 9,29 mld. | ||
-.--% | -.--% | 16.97x | 3,110 | 3.15x | 11.31x | 12.52x | 7,5 mld. | ||
+0.15% | +0.31% | 68.78x | 8,409 | 21.83x | 158.05x | 116.85x | 7,14 mld. | ||
Gemiddelde | +0,17% | +0,20% | -50,67x | 1,14 | 18,22x | 6,70x | 12,43x | 29,61 mld. | |
Gewogen gemiddelde per kap. | +0,09% | +0,10% | -98,94x | 3,77 | 11,99x | 33,78x | 50,26x |
- Beurs
- Aandelen
- Koers PHXM
- Koers PHXM
- Sector PHAXIAM Therapeutics S.A.
- Sectorale dividenden